Aurora Cannabis Inc. Announces Global Medical Cannabis Portfolio Expansion

Aurora Cannabis Inc. is expanding its global medical cannabis portfolio with new product launches in Canada, Europe, and Australia. These launches include dried flower, pre-rolls, and pastilles, reinforcing the company's medical-first strategy and focus on quality, patient needs, and reliable global supply. The expansion leverages Aurora's GMP-certified manufacturing network and aims to meet growing demand in regulated international markets. New products include expanded offerings in Germany, Poland, Australia (introducing pastilles), and Canada, featuring various strains and formats. Aurora aims to advance the regulated medical cannabis sector worldwide by providing high-quality products and diverse options.